Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02067377 · ClinicalTrials.gov registry record · NA
Efficacy of Serum Bovine Immunoglobulin in Improving Nutritional Status in Advanced COPD
A NA study of Advanced COPD (GOLD Stage 3 or 4) With Cachexia, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT02067377: Completed NA study of Advanced COPD (GOLD Stage 3 or 4) With Cachexia, sponsored by Medical University of South Carolina.
NCT02067377 is a NA study of Advanced COPD (GOLD Stage 3 or 4) With Cachexia that has completed, run by Medical University of South Carolina. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02067377, a NA study of Advanced COPD (GOLD Stage 3 or 4) With Cachexia, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the use of a medical food, oral serum-derived bovine immunoglobulin/protein isolate (SBI), in helping patients with advanced COPD with cachexia (a wasting syndrome) improve their nutritional status and gain weight. The medical food is in powder form and is mixed with a liquid such as water or orange juice and consumed by swallowing. The primary hypothesis is that SBI protein isolate (SBI) will improve the nutritional status of cachexic patients with advanced stages of COPD.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Serum bovine immunoglobulin (SBI) medical food
- DIETARY_SUPPLEMENT Placebo (for serum bovine immunoglobulin)
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2013-12 |
| Phase | NA |
What the finished NCT02067377 record still lists
NCT02067377 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Advanced COPD (GOLD Stage 3 or 4) With Cachexia appearing as the primary indexed condition, and to 2 interventions - of which Serum bovine immunoglobulin (SBI) medical food is the first listed.
NCT02067377 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT02067377 about?
NCT02067377 is a clinical study titled "Efficacy of Serum Bovine Immunoglobulin in Improving Nutritional Status in Advanced COPD". This study will evaluate the use of a medical food, oral serum-derived bovine immunoglobulin/protein isolate (SBI), in helping patients with advanced COPD with cachexia (a wasting syndrome) improve their nutritional status and gain weight. The medical food is in powder form and is mixed with a liqui...
What is the current status of trial NCT02067377?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2013-12.
What conditions does trial NCT02067377 study?
This clinical trial studies the following conditions: Advanced COPD (GOLD Stage 3 or 4) With Cachexia.
What interventions are being tested in trial NCT02067377?
The interventions under investigation include: Serum bovine immunoglobulin (SBI) medical food (DIETARY_SUPPLEMENT), Placebo (for serum bovine immunoglobulin) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02067377?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02067377 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02067377's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia